BD (US), Beckman Coulter (US), and Thermo Fisher Scientific (US) are the Prominent Players in the Flow Cytometry Market

The major factors driving the growth of the flow cytometry market are the technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities and clinical trials, the growing focus on immunology and immuno-oncology research, high incidence and prevalence of HIV-AIDS and cancer, and availability of novel application-specific flow cytometry products.

The global Flow Cytometry Market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, at a CAGR of 8.1%

Recent Developments :-

• In 2018, Becton, Dickinson and Company (US) launched BD FACSymphony S6 High Parameter Cell Sorter.
• In 2018, Agilent Technologies, Inc. (US) entered into an agreement to acquire ACEA Biosciences Inc. (US) to expand its global revenue base, product portfolio, and strengthen its market share.
• In 2018, Merck KGaA (Germany) launched the CellStream benchtop flow cytometer system.

Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

The growing market penetration in emerging countries, growth in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry technologies are expected to present a wide range of growth opportunities for market players.

The flow cytometry market is segmented on the basis of products and services into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables segment is expected to command the largest share of the global flow cytometry market in 2018. Factors such as the development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end users (due to the increasing number of flow cytometry-based research activities) are expected to drive the growth of the reagents and consumables market in the coming years.

Geographical Analysis:-
The market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of APAC), Latin America (Brazil, Mexico, and the Rest of LATAM), and the Middle East and Africa. North America is expected to account for the largest share of the global flow cytometry market in 2018.

Read more ( Flow cytometry market ): https://www.marketsandmarkets.com/PressReleases/flow-cytometry.asp

Major Key players :-
The major players operating in the flow cytometry market are Becton, Dickinson and Company (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (US), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US) and Apogee Flow Systems Ltd. (UK).

Particle Size Analysis Market: Drivers, Restraints, Opportunities and Challenges

The major factors driving the growth of the Particle Size Analysis Market include increasing research activities in the field of nanotechnology; technological advancements in particle size analyzers; increasing investment in pharmaceutical R&D; and stringent regulatory guidelines for product quality across industries.

The global particle size analysis market is expected to reach USD 405.0 Million by 2022 from USD 314.3 Million in 2017, at a CAGR of 5.2%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 

Market Drivers: -
            1.Increasing Research Activities in the Field of Nanotechnology
            2.Technological Advancements in Particle Size Analyzers
            3.Increasing Investments in Pharmaceutical R&D
            4.Development of Technologically Advanced Instruments Requiring Low Sample Volumes and Preparation Time
            5.Stringent Regulatory Guidelines for Product Quality Across Industries
            6.Funding Activities Increasing the Purchasing Power of Research Institutions
is attributed to laser diffraction’s wide dynamic measurement range, a feature that significantly increases its application areas.

Industry Analysis:-
Based on the type of industry, the global particle size analysis market is classified into five major segments—healthcare; chemicals and petroleum; mining, minerals, and cement; food and beverage; and other industries. The last segment comprises industries related to inks, toners, paint, coatings, cosmetics, and environmental analysis. The healthcare industry segment is expected to account for the largest share of the particle size analysis market in 2017 due to its dominance can be attributed to the increasing applications of nanotechnology in medical science, the rapid growth of pharmaceuticals in the healthcare industry.

Read More :- ( Particle size analysis market) : https://www.marketsandmarkets.com/PressReleases/particle-size-analysis.asp  

Geographical Analysis:
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the global particle size analysis market during the forecast period (2017-2022). The large share of this region can be attributed to the increasing government support for nanotechnology research and strict regulatory guidelines on product quality. In addition, increasing efforts by market players to expand their business in the US is one of the key factors propelling the growth of particle size analysis in North America.

Key Players:-

The major players operating in the particle size analysis market include Malvern Instruements Limited (UK), HORIBA, Ltd. (Japan), and Beckman Coulter, Inc. (US).

In Vitro Diagnostics (IVD) Market by Technology, Application & Product - 2023

Factors such as increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, increasing adoption of fully-automated instruments and automation in laboratories, and increasing adoption of point-of-care testing are driving the market growth.

The In Vitro Diagnostics Market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%.

The oncology segment is expected to grow at the highest CAGR in the in vitro diagnostics market

The IVD market, by application is segmented into infectious diseases, diabetes, oncology, cardiology, drug testing/pharmacogenomics, HIV/AIDS, autoimmune diseases, nephrology, and other applications (including genetic disease screening and human leukocyte antigen typing). The infectious diseases accounted for the largest share of this market, while oncology is expected to grow at the highest CAGR during the forecast period. The increasing number of cancer cases across the globe, growing demand for personalized medicine treatment, the increasing utility of biomarkers, and availability of funding for cancer research are some of the major factors propelling the growth of this application segment.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703

Point-of-care testing segment will continue to grow at higher rate till 2023. On the basis of end users, the in vitro diagnostics market is segmented into hospitals, laboratories, poit-of-care testing, patient self-testing, academic institutes, and other end users. The hospitals segment held the largest share of this market in 2017, while point-of-care testing segment is expected to register highest growth during the forecast period.

Regional Analysis:-

The in vitro diagnostics market, by region, has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2017, North America dominates the market; and Asia Pacific is expected to witness the highest CAGR during the forecast period, owing to factors such as government efforts to increase awareness about the early detection of diseases and regular health check-ups; continuously rising healthcare expenditure; increasing number of hospitals and clinical diagnostic laboratories in India and China; and strengthening research base for diagnostic procedures across India, China, and Japan.

Read More: - https://www.marketsandmarkets.com/PressReleases/ivd-in-vitro-diagnostics.asp

Top Key players:-
The top five players in this market hold a share of ~55–60% in 2017. Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US) are the leading players in this market.

Sleep Apnea Oral Appliances Market by Type & Product - 2023

The Sleep Apnea Oral Appliances Market is projected to reach USD 482.5 Million by 2023 from an estimated USD 233.2 Million in 2018, at a CAGR of 15.7%. Growth in this market is mainly driven by the growing popularity of oral appliances in sleep apnea management, technological advancements in oral appliances, a large pool of undiagnosed sleep apnea patients, and growing awareness about sleep apnea.

Markets Drivers:-
                    1 Growing Popularity of Oral Appliances in Sleep Apnea Management
                    2 Technological Advancements in Oral Appliances
                    3 Large Pool of Undiagnosed Sleep Apnea Patients
                    4 Growing Awareness About Sleep Apnea

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownload.asp?id=105423877

Physician-prescribed/Customized Oral Appliances to dominate the sleep apnea oral appliances market during the forecast period
By type, physician-prescribed/customized oral appliances segment is projected to grow at the highest CAGR during the forecast period. The high growth can be attributed to the rising awareness of sleep apnea and increasing patient preference for prescribed and customized oral appliances.

Regional Analysis:-
North America is expected to account for the largest share of the sleep apnea oral appliances market in 2018. The rising prevalence of sleep apnea in the region coupled with the growing demand for alternative treatment options due to poor compliance associated with CPAP is driving the sleep apnea oral appliances market in the region.
In addition, rising awareness regarding the disorder; less complicated reimbursement scenario for oral appliance therapy (OAT); and increased acceptance of OAT by physicians, dentists, patients, and insurance companies are also supporting the growth of the sleep apnea oral appliances market in North America.

Read more: - https://www.marketsandmarkets.com/PressReleases/sleep-apnea-oral-appliances.asp

Top Key Players:-
ResMed (US), SomnoMed (Australia), and Whole You (US) are the key players in the sleep apnea oral appliances market. Other players involved in this market are Oventus (Australia), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), and Myerson (US).

North America to Witness the Highest Growth Rate in the High-Throughput Screening Market

The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.
The report High Throughput Screening Market is expected to reach USD 29.29 billion by 2027 from an estimated USD 14.95 billion in 2019, at a CAGR of 7.8%.

The reagents & assay kits segment accounted for the largest share of the HTS market in 2018

On the basis of product and service, the reagents & assay kits segment accounted for the largest share of the global HTS market. The large share of this segment can be attributed to factors such as the large numbers of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

The cell-based assays segment held the largest share in 2018

Based on technology, the HTS market is segmented into cell-based assays, lab-on-a-chip (LOC), ultra-high-throughput screening (uHTS), label-free technology, and bioinformatics. In 2018, the cell-based assays segment accounted for the largest share of the HTS market.

The pharmaceutical and biotechnology companies segment held the largest share of the HTS market in 2018

Based on end user, the pharmaceutical and biotechnology companies segment accounted for the largest share of the HTS market. Factors such as the increasing use of HTS techniques by pharmaceutical and biotechnology companies for drug discovery applications along with the increasing pharmaceutical R&D expenditure are driving the growth of this segment.

North America dominated the market in 2018

North America accounted for the largest share of the HTS market in 2018, followed by Europe and Asia Pacific. The large spending on pharmaceutical R&D, growing adoption of HTS, availability of government funding, and the presence of major key players in the region are the major factors responsible for the large share of the North American HTS market.

Read more: - https://www.marketsandmarkets.com/PressReleases/high-throughput-screening.asp

The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).